 

FINDINGS OF FACT

Panel B has made the following findings of fact:
Background

1, At all relevant times, the Respondent was and is licensed to practice medicine in
the State of Maryland. The Respondent was initially licensed to practice medicine in Maryland on
June 27, 1990, under License Number D40208. The Respondent's license is active through
September 30, 2022.

2. The Respondent is board-certified in internal medicine.

3. At all relevant times, the Respondent practiced at a medical office in Baltimore
County, Maryland 21061.
Referral from the Maryland Office of Controlled Substances Administration

4. The Board initiated an investigation of the Respondent under Case Number 2221 -
0117B after receiving a referral, dated April 7, 2021 from the Maryland Office of Controlled
Substances Administration (“OCSA”). The OCSA stated that based on its professional judgment,
it was referring the Respondent for “for possible inappropriate prescribing of controlled dangerous
substance (“CDS”) prescriptions, specifically high doses of opioids (higher than the maximum
recommended doses per CDC) and sometimes concurrently prescribed opioids with promethazine
with codeine, benzodiazepines and/or carisoprodol (increasing the risk of overdose death) which
is against the CDC and product manufacturer recommendations.”
Board’s request to Respondent for written response to the OCSA allegations

5. By letter dated May 6, 2021, the Board notified the Respondent that it had initiated an
investigation of her after receiving the OCSA’s referral. The Board provided the Respondent with

the OCSA report and requested that she address it in a written response within ten business
